103 related articles for article (PubMed ID: 9395092)
1. Design of mu selective opioid dipeptide antagonists.
Capasso A; Amodeo P; Balboni G; Guerrini R; Lazarus LH; Temussi PA; Salvadori S
FEBS Lett; 1997 Nov; 417(1):141-4. PubMed ID: 9395092
[TBL] [Abstract][Full Text] [Related]
2. Bioactivity of new mu and delta opioid peptides.
Capasso A
Med Chem; 2007 Sep; 3(5):480-7. PubMed ID: 17897075
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationships of dermorphin analogues containing N-substituted amino acids in the 2-position of the peptide sequence.
Schmidt R; Kálmán A; Chung NN; Lemieux C; Horváth C; Schiller PW
Int J Pept Protein Res; 1995 Jul; 46(1):47-55. PubMed ID: 7558596
[TBL] [Abstract][Full Text] [Related]
4. Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivatives with extraordinary delta opioid antagonist activity.
Salvadori S; Balboni G; Guerrini R; Tomatis R; Bianchi C; Bryant SD; Cooper PS; Lazarus LH
J Med Chem; 1997 Sep; 40(19):3100-8. PubMed ID: 9301674
[TBL] [Abstract][Full Text] [Related]
5. Delta opioidmimetic antagonists: prototypes for designing a new generation of ultraselective opioid peptides.
Salvadori S; Attila M; Balboni G; Bianchi C; Bryant SD; Crescenzi O; Guerrini R; Picone D; Tancredi T; Temussi PA
Mol Med; 1995 Sep; 1(6):678-89. PubMed ID: 8529134
[TBL] [Abstract][Full Text] [Related]
6. Selective opioid dipeptides.
Temussi PA; Salvadori S; Amodeo P; Bianchi C; Guerrini R; Tomatis R; Lazarus LH; Picone D; Tancredi T
Biochem Biophys Res Commun; 1994 Feb; 198(3):933-9. PubMed ID: 8117299
[TBL] [Abstract][Full Text] [Related]
7. The TIPP opioid peptide family: development of delta antagonists, delta agonists, and mixed mu agonist/delta antagonists.
Schiller PW; Weltrowska G; Berezowska I; Nguyen TM; Wilkes BC; Lemieux C; Chung NN
Biopolymers; 1999; 51(6):411-25. PubMed ID: 10797230
[TBL] [Abstract][Full Text] [Related]
8. Subtleties of structure-agonist versus antagonist relationships of opioid peptides and peptidomimetics.
Schiller PW; Weltrowska G; Schmidt R; Berezowska I; Nguyen TM; Lemieux C; Chung NN; Carpenter KA; Wilkes BC
J Recept Signal Transduct Res; 1999; 19(1-4):573-88. PubMed ID: 10071786
[TBL] [Abstract][Full Text] [Related]
9. Side chain methyl substitution in the delta-opioid receptor antagonist TIPP has an important effect on the activity profile.
Tourwé D; Mannekens E; Diem TN; Verheyden P; Jaspers H; Tóth G; Péter A; Kertész I; Török G; Chung NN; Schiller PW
J Med Chem; 1998 Dec; 41(26):5167-76. PubMed ID: 9857087
[TBL] [Abstract][Full Text] [Related]
10. Differential stereochemical requirements of mu vs. delta opioid receptors for ligand binding and signal transduction: development of a class of potent and highly delta-selective peptide antagonists.
Schiller PW; Nguyen TM; Weltrowska G; Wilkes BC; Marsden BJ; Lemieux C; Chung NN
Proc Natl Acad Sci U S A; 1992 Dec; 89(24):11871-5. PubMed ID: 1334552
[TBL] [Abstract][Full Text] [Related]
11. Potent Dmt-Tic pharmacophoric delta- and mu-opioid receptor antagonists.
Li T; Fujita Y; Shiotani K; Miyazaki A; Tsuda Y; Ambo A; Sasaki Y; Jinsmaa Y; Marczak E; Bryant SD; Salvadori S; Lazarus LH; Okada Y
J Med Chem; 2005 Dec; 48(25):8035-44. PubMed ID: 16335927
[TBL] [Abstract][Full Text] [Related]
12. Design of opioid peptides for a potential delta-receptor affinity label function: comparison with the mu-specific Tyr-D-Ala-Gly-(Me)Phe-chloromethyl ketone.
Rónai AZ; Hepp J; Magyar A; Borsodi A; Medzihradszky K
Pharmacology; 1994 Aug; 49(2):121-31. PubMed ID: 7972321
[TBL] [Abstract][Full Text] [Related]
13. Probing the shape of a hydrophobic pocket in the active site of delta-opioid antagonists.
Santagada V; Caliendo G; Severino B; Perissutti E; Ceccarelli F; Giusti L; Mazzoni MR; Salvadori S; Temussi PA
J Pept Sci; 2001 Jul; 7(7):374-85. PubMed ID: 11495498
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
[TBL] [Abstract][Full Text] [Related]
15. Novel peptidic mu opioid antagonists: pharmacologic characterization in vitro and in vivo.
Kramer TH; Shook JE; Kazmierski W; Ayres EA; Wire WS; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1989 May; 249(2):544-51. PubMed ID: 2566679
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and pharmacological properties of a new fluorescent opioid peptide analog.
Lukowiak M; Kosson P; Hennink WE; Lipkowski AW
Pharmacol Rep; 2009; 61(4):727-31. PubMed ID: 19815956
[TBL] [Abstract][Full Text] [Related]
17. Cyclic opioid peptide agonists and antagonists obtained via ring-closing metathesis.
Berezowska I; Lemieux C; Chung NN; Wilkes BC; Schiller PW
Chem Biol Drug Des; 2009 Oct; 74(4):329-34. PubMed ID: 19694755
[TBL] [Abstract][Full Text] [Related]
18. Design, Synthesis and Functional Analysis of Cyclic Opioid Peptides with Dmt-Tic Pharmacophore.
Sarkar A; Adamska-Bartlomiejczyk A; Piekielna-Ciesielska J; Wtorek K; Kluczyk A; Borics A; Janecka A
Molecules; 2020 Sep; 25(18):. PubMed ID: 32957550
[TBL] [Abstract][Full Text] [Related]
19. Novel [D-Arg2]dermorphin(1-4) analogs with mu-opioid receptor antagonist activity.
Ambo A; Terashima T; Sasaki Y
Chem Pharm Bull (Tokyo); 2002 Oct; 50(10):1401-3. PubMed ID: 12372875
[TBL] [Abstract][Full Text] [Related]
20. Stereospecific synthesis of (2S)-2-methyl-3-(2',6'-dimethyl-4'-hydroxyphenyl)-propionic acid (Mdp) and its incorporation into an opioid peptide.
Lu Y; Weltrowska G; Lemieux C; Chung NN; Schiller PW
Bioorg Med Chem Lett; 2001 Feb; 11(3):323-5. PubMed ID: 11212101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
